Application of the concetrations ratio of soluble receptor tyrosine kinase type 1, and placental growth factor for short-term prediction and diagnosis of preeclampsia
Authors:
Š. Bubeníková 1; A. Cíchová 1; L. Roubalová 2; V. Durdová 3
; R. Vlk 4
Authors‘ workplace:
Ústav porodní asistence, Fakulta zdravotnických věd, Univerzita Palackého, Olomouc, přednosta prof. MUDr. M. Procházka, Ph. D.
1; Oddělení klinické biochemie Fakultní nemocnice, Olomouc, vedoucí oddělení prof. RNDr. T. Adam, Ph. D.
2; Porodnicko-gynekologická klinika LF UP a FN, Olomouc, přednosta prof. MUDr. R. Pilka, Ph. D.
3; Gynekologicko-porodnická klinika 2. LF UK a FN Motol, Praha, přednosta MUDr. R. Chmel, Ph. D.
4
Published in:
Ceska Gynekol 2016; 81(4): 272-278
Overview
Objective:
Bring a comprehensive overview of the available information about applications of the concetration ratio of soluble receptor tyrosine kinase type 1 (sFlt-1), and placental growth factor for short-term prediction and diagnosis of preeclampsia.
Design:
Overview study.
Settings:
Department of Midwifery, Faculty of Health Sciences, Olomouc; Department of Clinical Biochemistry, University Hospital Olomouc; Department of Obstetrics and Gynecology, University Hospital Olomouc; Department of Obstetrics and Gynecology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital.
Methods:
Analysis of literary sources and databases Ovid, Medline (2001–2016).
Conclusion:
Preeclampsia is a multisystem disease with not fully understood etiology. This disease occurs in 2–5% of pregnant women. Preeclampsia is one of the main causes of global maternal and perinatal morbidity and mortality. It manifests itself as a newborn hypertension and proteinuria after 20 weeks of pregnancy in previously normotensive women. The only effective treatment is the delivery of the child. Diagnosis of preeclampsia comprises measuring blood pressure and proteinuria. These indicators have low diagnostic sensitivity and specificity. In preeclampsia, there is a decrease of serum levels of placental growth factor (PlGF). Soluble receptor tyrosine kinase type 1 (sFlt-1) is an antagonist of PlGF. Increased levels of sFlt-1 in proportion to the reduced level of PlGF are associated with an increased risk of preeclampsia. The sFlt-1/PlGF ratio can be a better predictive marker in the diagnosis of pre-eclampsia after 20 weeks of gestation.
Keywords:
preeclampsia, prediction, angiogenic factors, soluble fms-like tyrosine kinase, sFlt-1, placental growth factor PlGF, the sFlt-1/PlGF ratio
Sources
1. Akolekar, R., Zaragoza, E., Poon, LC., et al. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol, 2008, 32(6), p. 732–739. Dostupné z doi:10.1002/uog.6244.
2. Burton, GJ. Oxygen, the janus gas, its effects on human placental development and functions. J Anatomy, 2009, 215(1), p. 27–35. Dostupné z doi: 10.1111/j.1469-7580.2008.00978.x.
3. Cerdeira, AS., Karumanchi, SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med, 2012, 2(11). Dostupné z doi: 10.1101/cshperspect.a006585.
4. Hájek, Z. Rizikové a patologické těhotenství. Praha: Grada Publishing, 2004, 443 s.
5. Hájek, Z., Čech, E., Maršál K. Porodnictví 3, zcela přepracované a doplněné vydání. Praha: Grada, 2014, 580 s.
6. Herraiz, I., Simón, E., Gómez-Arriaga P., et al. Angiogenesis-related biomarkers (sFlt-1/PlGF) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration. Inter J Molecular Sci, 2015, 16(8), p. 19009-19026. Dostupné z doi: 10.3390/ijms160819009.
7. Hund, M., Allegranza, D., Schoedl, M., et al. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy and Childbirth, 2014, 14(1), p. 324. Dostupné z doi: 10.1186/1471-2393-14-324.
8. Chamy, VM., Lepe, J., Catalán, Á., et al. Oxidative stress is closely related to clinical severity of pre-eclampsia. Biol Res, 2006, 39(2). Dostupné z doi: 10.4067/S0716-97602006000200005.
9. Lai, J., Poon, LCY., Bakalis, S., et al. Systolic, diastolic and mean arterial pressure at 30-33 weeks in the prediction of preeclampsia. Fetal Diag Ther, 2013, 33(3), p. 173–181. Dostupné z doi: 10.1159/000345950.
10. Leahomschi, S., Calda, P. Preeklampsie v těhotenství – predikce, prevence a další management. Čes Gynek, 2014, 79(5), s. 356–362.
11. Levine, R., Maynard, SE., Qian, C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004, 350(7), p. 672–683.
12. Levine, RJ., Lam, C., Qian, C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med, 2006, 355(10), p. 992–1005.
13. Magee, LA., Pels, A., Helewa, M., et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertension. Inter J Women‘s Cardiovascular Health, 2014, 4(2), p. 105–145 Dostupné z doi: 10.1016/j.preghy.2014.01.003.
14. Maynard, SE., Karumanchi, SA. Angiogenic factors and preeclampsia. Seminars in Nephrology, 2011, 31(1), p. 33–46. Dostupné z doi: 10.1016/j.semnephrol.2010.10.004.
15, Maynard, SE., Min, JY., Merchan, J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest, 2003, 111(5), p. 649–658.
16. Pereira, RD., Long, NE., Wang, RC., et al. Angiogenesis in the placenta: the role of reactive oxygen species signaling. BioMed Res Inter, 2015. Dostupné z doi:10.1155/2015/814543.
17. Reynolds, LP., Redmer, DA. Angiogenesis in the placenta. Biol Reprod, 2001, 64(4), p. 1033–1040.
18. Staff, AC., Benton, SJ., Dadelszen, P., et al. Redefining preeclampsia using placenta-derived biomarkers. Hypertension, 2013, 61(5), p. 932–942. Dostupné z doi: 10.1161/HYPERTENSIONAHA.111.00250.
19. Stepan, H., Herraiz, I., Schlembach, D., et al. Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol, 2015, 45(3), p. 241–246. Dostupné z: http://doi.wiley.com/10.1002/uog.14799.
20. Thomas, CP., Andrews, JI., Liu, KZ. Intronic polyadelation signal sequences and alternace splicing generace human soluble Flt-1 variants and regulace the abundance of soluble Flt-1 in the placenta. FASEB J, 2007, 21(14), p. 3885–3895.
21. Tsiakkas, A., Duvdevani, N., Wright, A., et al. Serum soluble fms-like tyrosine konase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 2015, 45(5), p. 584–590. Dostupné z doi: 10.1002/uog.14817.
22. Tsiakkas, A., Duvdevani, N., Wright, A., et al. Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol, 2015, 45(5), p. 591–598. Dostupné z doi: 10.1002/uog.14811.
23. Verlohren, S., Herraiz, I., Lapaire, O., et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol, 2012, 206(1). Dostupné z doi: 10.1016/j.ajog.2011.07.037.
24. Vlk, R. Preeklampsie. Praha: Maxdorf, 2015, 349 s.
25. Wang, A., Rana, S., Karumanchi, SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology, 2009, 24(3), p. 147–158. Dostupné z doi: 10.1152/physiol.00043.2008.
26. Zeisler, H., Llurba, E., Chantraine, F., et al. Predictive value of the sflt-1:plgf ratio in women with suspected preeclampsia. New Engl J Med, 2016, 1(7), p. 13–22. Dostupné z doi: 10.1056/NEJMoa1414838.
Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicineArticle was published in
Czech Gynaecology
2016 Issue 4
Most read in this issue
- Technique of pelvic and paraaortic lymphadenectomy
- Prague 1337: the first successful caesarean section in which both mother and child survived may have occurred in the court of John of Luxembourg, King of Bohemia
- Present properties of ultrasound diagnostics in urogynecology
- Fetal alloimmune thrombocytopenia in pregnant woman with anti-HPA-1a antibodies